Advanced Diabetes Supply (ADS) has announced the appointment of three executives.
In a Jan. 18 news announcement, ADS introduced Sean Muniz as Chief Supply Chain Officer; Melanie Montero as Revenue Cycle Leader; and Walt Meffert as Chief Transformation Officer.
Bill Mixon, CEO of ADS, said in the announcement, “We are pleased to welcome these seasoned leaders to the ADS executive team.”
“Their experience, expertise and commitment to excellence will be invaluable as we navigate a future of transformational growth,” Mixon continued. “It is an exciting time in our company as we expand to provide new and innovative ways to serve the diabetic community.”
ADS distributes specialized diabetes supplies across the United States via the ADS and USMED brands.
The goal of ADS is to “lead the diabetes industry with diligence and persistence, pioneering efforts to deliver an innovative, refined, quality service experience in the DME diabetes supply space,” the company said in the announcement.
Muniz, the new Chief Supply Officer, will oversee the direction and leadership “of the company’s operational, financial, programmatic and personnel supply chain activities. He will work closely with ADS strategic partners and suppliers to maximize value and optimize the supply chain processes.”
Montero, the new Revenue Cycle Leader, will lead ADS revenue cycle management operations. She succeeds Clydall Bobb, who is transferring to the ADS finance team under CFO Bart Witteveen.
As Chief Transformation Officer, Meffert will be in charge of leading the integration of business systems required to support ADS’s ongoing and rapid growth. He replaces Bill Monast, who will remain on the ADS board of directors.